Investment Research & Advisory Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77K | Sell |
1,115
-249
| -18% | -$17.2K | 0.03% | 96 |
|
|
2025
Q1 | $94.7K | Buy |
1,364
+424
| +45% | +$29.4K | 0.04% | 93 |
|
|
2024
Q4 | $80.9K | Hold |
940
| – | – | 0.03% | 95 |
|
|
2024
Q3 | $112K | Hold |
940
| – | – | 0.05% | 81 |
|
|
2024
Q2 | $134K | Hold |
940
| – | – | 0.06% | 73 |
|
|
2024
Q1 | $121K | Buy |
940
+112
| +14% | +$14.4K | 0.06% | 74 |
|
|
2023
Q4 | $85.7K | Buy |
828
+396
| +92% | +$41K | 0.04% | 85 |
|
|
2023
Q3 | $39.3K | Hold |
432
| – | – | 0.02% | 105 |
|
|
2023
Q2 | $35K | Hold |
432
| – | – | 0.02% | 113 |
|
|
2023
Q1 | $34.4K | Hold |
432
| – | – | 0.02% | 105 |
|
|
2022
Q4 | $29.2K | Hold |
432
| – | – | 0.02% | 104 |
|
|
2022
Q3 | $22K | Hold |
432
| – | – | 0.02% | 108 |
|
|
2022
Q2 | $24K | Hold |
432
| – | – | 0.02% | 110 |
|
|
2022
Q1 | $24K | Hold |
432
| – | – | 0.02% | 124 |
|
|
2021
Q4 | $24K | Hold |
432
| – | – | 0.01% | 125 |
|
|
2021
Q3 | $21K | Buy |
+432
| New | +$21K | 0.01% | 119 |
|